ARCHIVES

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

CCRAC Cool to Three Psychosocial Proposals, Approves One On Aging

October 26, 1979

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000